Efficacy and Safety of Ibuprofen in Patients With Ankle Injuries
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government.
Read our disclaimer for details.
A Randomised, Multicentre, Two-arm, Parallel Group, Double-blind, Placebo-controlled, Comparative Efficacy and Safety Clinical Study of Ibuprofen in Patients With Pain Related to Uncomplicated Ankle Injuries
Study Start Date
Primary Completion Date
Study Completion Date
Resource links provided by the National Library of Medicine
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.
Ages Eligible for Study:
18 Years to 45 Years (Adult)
Sexes Eligible for Study:
Accepts Healthy Volunteers:
Written informed consent obtained.
Male and female patients, age in the range of 18-45 years (inclusive).
Patients with pain related to uncomplicated ankle injuries (in case of doubt whether it is complicated an X-ray should be taken).
Pain related to ankle injuries is scored as moderate or severe by the patient and the injury is less than 24 hours old.
Patients with normal or clinically non-significant findings as determined by baseline history, physical examination and vital signs (blood pressure, heart rate and axillary temperature).
Comprehension of the nature and purpose of the study and compliance with the protocol requirements.
Negative urine pregnancy test (for females only).
Known hypersensitivity to aspirin or any non-steroidal anti-inflammatory drugs (NSAID).
Known history of asthma.
Known history of gastric or peptic ulcer or bleeding.
Known history of malignancy or other serious diseases.
Known history of skin allergy.
Known history of cardiac, renal or hepatic insufficiency.
Presence of bruises or rash on the skin of ankle.
Presence of skin lesions like eczema or psoriasis.
Arthritis in the same joint.
Alcohol use during the study period or within 48 hours before the study enrolment.
Patients judged unable to use the VAS for pain reliably
Locally applied NSAID to the painful region/area of study or oral use of NSAID or other analgesics 48 hours before the study enrolment.
Other pain killers than rescue medication to be taken during the study.
Recurrent sprain at the same joint during the last 6 months.
Physiotherapy during study period.
Open wounds, infected skin or fracture.
Any other condition that in the opinion of the investigator would interfere with the evaluation of the results or constitute a health risk for the patient.
Pregnant or lactating females.
Participation in a drug or device study within 90 days before the study enrolment.